BioSpace News Archive

The global digital health market is driven by a rising demand for improved communication between healthcare professionals and patients so as to reduce medication errors and provide improved coordinated care.

Augmented adoption of face masks as a tool of precaution to safeguard oneself from different diseases, such Ebola, swine flu, avian bird flu, influenza, Covid-19, and anthrax has played an important role in the development of the global reusable face mask market.

XNK Therapeutics AB announced the appointment of Dr. Johan Aschan as Chief Medical Officer, effective July 1st.

Highlight Therapeutics to present data from Phase 2 immunotherapy studies of liver metastases and melanoma data at AACR Virtual Annual Meeting 2021

GeneLeap Bio., a subsidiary of Luye Life Sciences specializing in the development of nucleic acid therapeutics, presented an ePoster entitled ‘Hydrogel encapsulated TLR9 agonists show sustained tumor growth inhibition and prolong survival of CT26 tumor-bearing mice’ at the American Association for Cancer Research 2021 Annual Meeting.

Talented team and industry-leading lab will help strengthen the company’s sequencing and pipeline capabilities, while broadening its therapy selection and treatment guidance offerings

Ventris Medical, a privately held orthobiologics company focused on design, development and commercialization of allografts and synthetic products for improving patient outcomes in Spinal Procedures and Wound Care, today announced the first use of its product Allocell® AF

HTL , the worldwide leader in biotechnology solutions using hyaluronic acid (HA) and other biopolymers, and Echelon Biosciences Inc. , a U.S.-based global supplier of biochemical reagents, assays, and services to research and development laboratories, announced today their new distribution and product development partnership.

Centogene N.V. announced that it has extended its partnership with Takeda Pharmaceutical Company Limited to diagnose patients with certain genetic disorders.

Zymergen Inc., one of the world’s foremost biofacturing companies, announced that it has launched the roadshow for the initial public offering of 13,600,000 shares of its common stock.